| Product Code: ETC9939984 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Cancer Diagnostics Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Cancer Diagnostics Market - Industry Life Cycle |
3.4 United Kingdom (UK) Cancer Diagnostics Market - Porter's Five Forces |
3.5 United Kingdom (UK) Cancer Diagnostics Market Revenues & Volume Share, By Diagnastic Type, 2021 & 2031F |
3.6 United Kingdom (UK) Cancer Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United Kingdom (UK) Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the United Kingdom |
4.2.2 Technological advancements in cancer diagnostics |
4.2.3 Growing awareness and focus on early detection and treatment of cancer |
4.3 Market Restraints |
4.3.1 High cost associated with cancer diagnostics procedures |
4.3.2 Limited access to advanced diagnostic technologies in certain regions |
4.3.3 Stringent regulatory requirements for cancer diagnostic tests |
5 United Kingdom (UK) Cancer Diagnostics Market Trends |
6 United Kingdom (UK) Cancer Diagnostics Market, By Types |
6.1 United Kingdom (UK) Cancer Diagnostics Market, By Diagnastic Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Cancer Diagnostics Market Revenues & Volume, By Diagnastic Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Cancer Diagnostics Market Revenues & Volume, By Diagnostic Imaging Tests, 2021- 2031F |
6.1.4 United Kingdom (UK) Cancer Diagnostics Market Revenues & Volume, By Biopsy and Cytology Tests, 2021- 2031F |
6.1.5 United Kingdom (UK) Cancer Diagnostics Market Revenues & Volume, By Tumor Biomarkers, 2021- 2031F |
6.1.6 United Kingdom (UK) Cancer Diagnostics Market Revenues & Volume, By Other Diagnostic Types, 2021- 2031F |
6.2 United Kingdom (UK) Cancer Diagnostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Cancer Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 United Kingdom (UK) Cancer Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.4 United Kingdom (UK) Cancer Diagnostics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.2.5 United Kingdom (UK) Cancer Diagnostics Market Revenues & Volume, By Kidney Cancer, 2021- 2031F |
6.2.6 United Kingdom (UK) Cancer Diagnostics Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.7 United Kingdom (UK) Cancer Diagnostics Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
7 United Kingdom (UK) Cancer Diagnostics Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Cancer Diagnostics Market Export to Major Countries |
7.2 United Kingdom (UK) Cancer Diagnostics Market Imports from Major Countries |
8 United Kingdom (UK) Cancer Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of innovative cancer diagnostic technologies |
8.2 Number of cancer screening programs implemented nationwide |
8.3 Percentage increase in cancer survival rates over time |
9 United Kingdom (UK) Cancer Diagnostics Market - Opportunity Assessment |
9.1 United Kingdom (UK) Cancer Diagnostics Market Opportunity Assessment, By Diagnastic Type, 2021 & 2031F |
9.2 United Kingdom (UK) Cancer Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United Kingdom (UK) Cancer Diagnostics Market - Competitive Landscape |
10.1 United Kingdom (UK) Cancer Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here